OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Distinct clinical outcomes and biological features of specific KRAS mutants in human pancreatic cancer
Caitlin A. McIntyre, Adrien Grimont, Jiwoon Park, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1614-1629.e5
Closed Access | Times Cited: 14
Caitlin A. McIntyre, Adrien Grimont, Jiwoon Park, et al.
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1614-1629.e5
Closed Access | Times Cited: 14
Showing 14 citing articles:
Unveiling the intriguing relationship: oncogenic KRAS , morphological shifts, and mutational complexity in pancreatic mucinous cystic neoplasms
Schulte, A. Beck, Ralf Marienfeld, et al.
The Journal of Pathology (2025)
Open Access | Times Cited: 1
Schulte, A. Beck, Ralf Marienfeld, et al.
The Journal of Pathology (2025)
Open Access | Times Cited: 1
Distinct molecular and clinical features of specific variants of KRAS codon 12 in pancreatic adenocarcinoma
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Clinical Cancer Research (2025)
Open Access
Bach Ardalan, Aaron Ciner, Yasmine Baca, et al.
Clinical Cancer Research (2025)
Open Access
Isoferulic Acid Inhibits Proliferation and Migration of Pancreatic Cancer Cells, and Promotes the Apoptosis of Pancreatic Cancer Cells in a Mitochondria‐Dependent Manner Through Inhibiting NF ‐κB Signalling Pathway
Suqin Sun, Rong Fan, Chang Li, et al.
Clinical and Experimental Pharmacology and Physiology (2025) Vol. 52, Iss. 3
Closed Access
Suqin Sun, Rong Fan, Chang Li, et al.
Clinical and Experimental Pharmacology and Physiology (2025) Vol. 52, Iss. 3
Closed Access
Prognostic Implications of Codon-Specific KRAS Mutations in Localized and Advanced Stages of Pancreatic Cancer.
Sara Raji, Hamed Zaribafzadeh, Tyler Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Sara Raji, Hamed Zaribafzadeh, Tyler Jones, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Recent Anti-KRASG12D Therapies: A “Possible Impossibility” for Pancreatic Ductal Adenocarcinoma
Navid Sobhani, Matteo Pittacolo, Alberto D’Angelo, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 704-704
Open Access
Navid Sobhani, Matteo Pittacolo, Alberto D’Angelo, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 704-704
Open Access
Inhibitors of oncogenic Kras specifically prime CTLA4 blockade to transcriptionally reprogram Tregs and overcome resistance to suppress pancreas cancer
Krishnan K. Mahadevan, Antonio Maldonado, Bingrui Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Krishnan K. Mahadevan, Antonio Maldonado, Bingrui Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
New exploration of KRASG12D inhibitors and the mechanisms of resistance
Yinghong Li, Junfeng Zhao, Yintao Li
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Yinghong Li, Junfeng Zhao, Yintao Li
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Precision Oncology in Pancreatic Cancer and Future Treatment Directions
Layal Al Mahmasani, Eileen M. O’Reilly
Surgical Oncology Clinics of North America (2025)
Closed Access
Layal Al Mahmasani, Eileen M. O’Reilly
Surgical Oncology Clinics of North America (2025)
Closed Access
The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer
M.C. Cox, Dominic Vitello, Akhil Chawla
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
M.C. Cox, Dominic Vitello, Akhil Chawla
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access
Precision Oncology: 2024 in Review
Matteo Repetto, Nicole Fernandez, Alexander Drilon, et al.
Cancer Discovery (2024) Vol. 14, Iss. 12, pp. 2332-2345
Closed Access | Times Cited: 2
Matteo Repetto, Nicole Fernandez, Alexander Drilon, et al.
Cancer Discovery (2024) Vol. 14, Iss. 12, pp. 2332-2345
Closed Access | Times Cited: 2
The KRAS mutational spectrum and its clinical implications in pancreatic cancer
Luigi Perelli, Giannicola Genovese, Giulio Draetta
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1494-1496
Closed Access
Luigi Perelli, Giannicola Genovese, Giulio Draetta
Cancer Cell (2024) Vol. 42, Iss. 9, pp. 1494-1496
Closed Access
Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas
Ellis L. Eikenboom, Naaz Nasar, Kenneth Seier, et al.
Annals of Surgical Oncology (2024)
Closed Access
Ellis L. Eikenboom, Naaz Nasar, Kenneth Seier, et al.
Annals of Surgical Oncology (2024)
Closed Access
STAT5: Understanding the Biology of KRASG12D‐Driven Pancreatic Cancer
Kostas A. Papavassiliou, Christos Adamopoulos, Athanasios G. Papavassiliou
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 24
Open Access
Kostas A. Papavassiliou, Christos Adamopoulos, Athanasios G. Papavassiliou
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 24
Open Access
TRIM21 Promotes Tumor Growth and Gemcitabine Resistance in Pancreatic Cancer by Inhibiting EPHX1‐Mediated Arachidonic Acid Metabolism
Xiaona Fan, Yisheng Dai, Chaohua Mo, et al.
Advanced Science (2024)
Open Access
Xiaona Fan, Yisheng Dai, Chaohua Mo, et al.
Advanced Science (2024)
Open Access
